Unlike the combination of radiation and cetuximab alone, the adaptive immune response unleashed by combination with anti–PD-L1 conveyed immunologic memory to those mice that were cured and this adaptive response was equally effective against huEGFR+ or huEGFR-deficient variants of the eradicated tumor line. This evidence concerns the gene CD274 and neoplasm.